Regression of Stage IV Pancreatic Cancer to Curative Surgery and Introduction of a Novel Ex-Vivo Chemosensitivity Assay

Although data suggests little hope for survival when patients present with metastatic pancreatic cancer, recent advances in systemic therapy offer the possibility for dramatic tumor responses like those observed in other disease sites. Here, we present the case of a 50-year-old woman who presented w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rios Perez, Mayrim V, Dai, Bingbing, Koay, Eugene J, Wolff, Robert A, Fleming, Jason B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727941/
https://www.ncbi.nlm.nih.gov/pubmed/26848412
http://dx.doi.org/10.7759/cureus.423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727941/
https://www.ncbi.nlm.nih.gov/pubmed/26848412
http://dx.doi.org/10.7759/cureus.423

Ejemplares similares